Samalin Investment Counsel LLC lifted its holdings in shares of Abrdn Healthcare Investors (NYSE:HQH – Free Report) by 7.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,844 shares of the financial services provider’s stock after buying an additional 4,875 shares during the quarter. Samalin Investment Counsel LLC owned approximately 0.14% of Abrdn Healthcare Investors worth $1,169,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in HQH. Raymond James Financial Inc. acquired a new position in shares of Abrdn Healthcare Investors during the 4th quarter worth approximately $15,049,000. Penserra Capital Management LLC acquired a new position in shares of Abrdn Healthcare Investors during the 3rd quarter worth approximately $16,145,000. Wolverine Asset Management LLC acquired a new position in shares of Abrdn Healthcare Investors during the 4th quarter worth approximately $2,196,000. Absolute Investment Advisers LLC acquired a new position in shares of Abrdn Healthcare Investors during the 4th quarter worth approximately $1,786,000. Finally, Oppenheimer & Co. Inc. raised its stake in shares of Abrdn Healthcare Investors by 94.6% during the 4th quarter. Oppenheimer & Co. Inc. now owns 174,268 shares of the financial services provider’s stock worth $2,797,000 after buying an additional 84,731 shares during the period. 32.60% of the stock is owned by institutional investors and hedge funds.
Abrdn Healthcare Investors Stock Up 0.4 %
Shares of HQH stock opened at $16.70 on Friday. The stock has a 50 day simple moving average of $17.34 and a 200-day simple moving average of $17.65. Abrdn Healthcare Investors has a 1-year low of $15.76 and a 1-year high of $19.79.
Abrdn Healthcare Investors Cuts Dividend
Abrdn Healthcare Investors Profile
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Recommended Stories
- Five stocks we like better than Abrdn Healthcare Investors
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Are Dividend Achievers? An Introduction
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- Ride Out The Recession With These Dividend Kings
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.